Latest Utilities News

Veris Limited has announced a significant turnaround in FY25 with an expected profit before tax of up to $2 million, reversing last year's loss, driven by strategic digital spatial initiatives and acquisition integration.

APA Group has announced an estimated ordinary dividend of AUD 0.30 per unit for the first half of 2025, accompanied by a Dividend Reinvestment Plan offering a 1.5% discount and currency payment choices.

Kingston Resources has restarted gold concentrate production at its Mineral Hill mine, marking a significant step in its transformation into a multi-product operation. The company aims to begin copper concentrate sales by mid-2026 as it transitions to underground mining.

X2M Connect has secured a $3 million deal to supply 100,000 IoT-connected personal safety devices for Seoul’s 2025 Smart City initiative, with potential to scale to one million units.

Riedel Resources launches a $1.3 million capital raise through a two-tranche placement and a Share Purchase Plan to advance its high-grade Kingman Gold Project in Arizona.

Pure Hydrogen Corporation has officially handed over the Taurus Hydrogen Fuel Cell Prime Mover to Barwon Water, marking a milestone in Australia’s hydrogen transport adoption and supporting Barwon Water’s net zero emissions goal by 2030.

Proteomics International has launched PromarkerD, a pioneering blood test that predicts diabetic kidney disease years before symptoms, marking its entry into the vast US healthcare market.

Catalyst Metals has completed its acquisition of the Old Highway Gold Project, setting the stage for a significant expansion across multiple mining sites in Western Australia.

X2M Connect Limited has secured $1.95 million through a share placement and convertible note conversion, aiming to strengthen its balance sheet and accelerate growth in AI and IoT sectors.

Argenica Therapeutics has reported compelling preclinical results for ARG-007, demonstrating sustained neuroprotection and functional recovery in a ferret model of moderate traumatic brain injury. These findings pave the way for clinical trials targeting a major unmet medical need.

Horizon Minerals reports robust progress at its Phillips Find and Boorara gold projects, delivering strong revenue and cashflow from recent toll processing campaigns. Upcoming plant treatments aim to complete the first mining phase and set the stage for improved cost performance.

Clarity Pharmaceuticals has partnered with SpectronRx to manufacture and distribute its lead prostate cancer diagnostic, Cu-64 SAR-bisPSMA, at commercial scale across the US. This agreement sets the stage for a seamless launch pending FDA approval.